PMC:7127386 / 9816-9958 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"239","span":{"begin":63,"end":77},"obj":"Disease"}],"attributes":[{"id":"A239","pred":"tao:has_database_id","subj":"239","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Oritavancin diphosphate antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 192564-14-0 N.D. \u003e100 N.D. N.D."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T29","span":{"begin":63,"end":67},"obj":"Body_part"}],"attributes":[{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma7163"}],"text":"Oritavancin diphosphate antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 192564-14-0 N.D. \u003e100 N.D. N.D."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T5","span":{"begin":63,"end":67},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"}],"text":"Oritavancin diphosphate antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 192564-14-0 N.D. \u003e100 N.D. N.D."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T61","span":{"begin":63,"end":77},"obj":"Disease"},{"id":"T62","span":{"begin":68,"end":77},"obj":"Disease"}],"attributes":[{"id":"A61","pred":"mondo_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/MONDO_0021201"},{"id":"A62","pred":"mondo_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Oritavancin diphosphate antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 192564-14-0 N.D. \u003e100 N.D. N.D."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T56","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"id":"T57","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/UBERON_0001003"},{"id":"T58","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/UBERON_0002097"},{"id":"T59","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/UBERON_0002199"},{"id":"T60","span":{"begin":63,"end":67},"obj":"http://www.ebi.ac.uk/efo/EFO_0000962"},{"id":"T61","span":{"begin":102,"end":110},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_2"}],"text":"Oritavancin diphosphate antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 192564-14-0 N.D. \u003e100 N.D. N.D."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T147","span":{"begin":0,"end":23},"obj":"Chemical"},{"id":"T148","span":{"begin":12,"end":23},"obj":"Chemical"},{"id":"T150","span":{"begin":24,"end":35},"obj":"Chemical"}],"attributes":[{"id":"A147","pred":"chebi_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/CHEBI_83305"},{"id":"A148","pred":"chebi_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/CHEBI_18361"},{"id":"A149","pred":"chebi_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/CHEBI_33019"},{"id":"A150","pred":"chebi_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":"Oritavancin diphosphate antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 192564-14-0 N.D. \u003e100 N.D. N.D."}

{"project":"LitCovid-sentences","denotations":[{"id":"T63","span":{"begin":0,"end":137},"obj":"Sentence"},{"id":"T64","span":{"begin":138,"end":142},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Oritavancin diphosphate antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 192564-14-0 N.D. \u003e100 N.D. N.D."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T5","span":{"begin":63,"end":77},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0100658"}],"text":"Oritavancin diphosphate antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 192564-14-0 N.D. \u003e100 N.D. N.D."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T63695","span":{"begin":0,"end":10},"obj":"SP_7"},{"id":"T53400","span":{"begin":14,"end":18},"obj":"CL_6"},{"id":"T59680","span":{"begin":94,"end":103},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T44493","span":{"begin":107,"end":111},"obj":"CL_6"}],"text":"Oritavancin diphosphate antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 192564-14-0 N.D. \u003e100 N.D. N.D."}